$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 2 3 4 5 6 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Grant | A | 106.46 | 25,085 | 2,670,549 | 251,645 | 226.6 K to 251.6 K (+11.07 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 106.46 | 277 | 29,489 | 24,977 | 25.3 K to 25 K (-1.10 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 106.46 | 837 | 89,107 | 25,253 | 24.4 K to 25.3 K (+3.43 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 106.46 | 277 | 29,489 | 24,977 | 25.3 K to 25 K (-1.10 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 106.46 | 837 | 89,107 | 25,253 | 24.4 K to 25.3 K (+3.43 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 106.46 | 2,517 | 267,960 | 27,390 | 29.9 K to 27.4 K (-8.42 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 106.46 | 5,018 | 534,216 | 29,907 | 24.9 K to 29.9 K (+20.16 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 106.46 | 2,517 | 267,960 | 27,390 | 29.9 K to 27.4 K (-8.42 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 106.46 | 5,018 | 534,216 | 29,907 | 24.9 K to 29.9 K (+20.16 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | M | 71.17 | 230,178 | 16,381,768 | 11,817 | |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 116.27 | 2,000 | 232,544 | 226,560 | 228.6 K to 226.6 K (-0.88 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 115.45 | 3,937 | 454,535 | 228,560 | 232.5 K to 228.6 K (-1.69 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 114.24 | 16,426 | 1,876,441 | 232,497 | 248.9 K to 232.5 K (-6.60 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 113.65 | 36,790 | 4,181,257 | 248,923 | 285.7 K to 248.9 K (-12.88 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 112.21 | 171,025 | 19,190,202 | 285,713 | 456.7 K to 285.7 K (-37.44 %) |
Mar 10 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Buy | M | 71.17 | 230,178 | 16,381,768 | 456,738 | 226.6 K to 456.7 K (+101.60 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 109.02 | 690 | 75,224 | 40,087 | 40.8 K to 40.1 K (-1.69 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 112.90 | 668 | 75,417 | 40,777 | 41.4 K to 40.8 K (-1.61 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 111.09 | 321 | 35,660 | 41,445 | 41.8 K to 41.4 K (-0.77 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 109.02 | 789 | 86,017 | 68,411 | 69.2 K to 68.4 K (-1.14 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 112.90 | 777 | 87,723 | 69,200 | 70 K to 69.2 K (-1.11 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 111.09 | 368 | 40,881 | 69,977 | 70.3 K to 70 K (-0.52 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 109.02 | 1,100 | 119,922 | 38,105 | 39.2 K to 38.1 K (-2.81 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 112.90 | 1,187 | 134,012 | 39,205 | 40.4 K to 39.2 K (-2.94 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 111.09 | 510 | 56,656 | 40,392 | 40.9 K to 40.4 K (-1.25 %) |
Feb 27 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 112.90 | 1,195 | 134,916 | 69,756 | 71 K to 69.8 K (-1.68 %) |
Feb 27 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 112.90 | 4,299 | 485,357 | 226,560 | 230.9 K to 226.6 K (-1.86 %) |
Feb 27 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 112.90 | 773 | 87,272 | 24,889 | 25.7 K to 24.9 K (-3.01 %) |
Feb 27 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 112.90 | 98 | 11,064 | 24,416 | 24.5 K to 24.4 K (-0.40 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 113.34 | 49 | 5,554 | 24,514 | 24.6 K to 24.5 K (-0.20 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 112.17 | 56 | 6,282 | 24,563 | 24.6 K to 24.6 K (-0.23 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 113.34 | 552 | 62,564 | 40,902 | 41.5 K to 40.9 K (-1.33 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 112.73 | 598 | 67,413 | 41,454 | 42.1 K to 41.5 K (-1.42 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 112.17 | 643 | 72,125 | 42,052 | 42.7 K to 42.1 K (-1.51 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 113.34 | 307 | 34,795 | 41,766 | 42.1 K to 41.8 K (-0.73 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 112.17 | 382 | 42,849 | 42,073 | 42.5 K to 42.1 K (-0.90 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 113.34 | 423 | 47,943 | 25,662 | 26.1 K to 25.7 K (-1.62 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 112.17 | 515 | 57,768 | 26,085 | 26.6 K to 26.1 K (-1.94 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 113.34 | 2,074 | 235,067 | 230,859 | 232.9 K to 230.9 K (-0.89 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 112.17 | 2,404 | 269,657 | 232,933 | 235.3 K to 232.9 K (-1.02 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 113.34 | 356 | 40,349 | 70,345 | 70.7 K to 70.3 K (-0.50 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 112.73 | 405 | 45,656 | 70,701 | 71.1 K to 70.7 K (-0.57 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 112.17 | 432 | 48,457 | 71,106 | 71.5 K to 71.1 K (-0.60 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | A | 112.17 | 5,059 | 567,468 | 5,059 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 0.00 | 776 | 0 | 24,619 | 23.8 K to 24.6 K (+3.25 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | A | 112.17 | 145,361 | 16,305,143 | 145,361 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Grant | A | 0.00 | 22,288 | 0 | 235,337 | 213 K to 235.3 K (+10.46 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 112.17 | 22,677 | 2,543,679 | 22,677 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 3,477 | 0 | 42,455 | 39 K to 42.5 K (+8.92 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | A | 112.17 | 40,120 | 4,500,260 | 40,120 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 0.00 | 6,152 | 0 | 42,695 | 36.5 K to 42.7 K (+16.83 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 112.17 | 34,887 | 3,913,275 | 34,887 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 5,350 | 0 | 29,976 | 24.6 K to 30 K (+21.73 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | A | 112.17 | 40,120 | 4,500,260 | 40,120 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 0.00 | 6,152 | 0 | 72,169 | 66 K to 72.2 K (+9.32 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 112.17 | 26,165 | 2,934,928 | 26,165 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 4,012 | 0 | 71,538 | 67.5 K to 71.5 K (+5.94 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Option Exercise | A | 112.17 | 34,887 | 3,913,275 | 34,887 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 0.00 | 5,350 | 0 | 26,600 | 21.3 K to 26.6 K (+25.18 %) |
Feb 10 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Gift | G | 0.00 | 480 | 0 | 38,978 | 39.5 K to 39 K (-1.22 %) |
Jan 06 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 106.52 | 1,543 | 164,360 | 21,250 | 22.8 K to 21.3 K (-6.77 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 291 | 0 | 8,988 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 291 | 0 | 8,988 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 66.51 | 77,865 | 5,178,801 | 0 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 66.51 | 77,865 | 5,178,801 | 0 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 71.17 | 65,681 | 4,674,517 | 0 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 71.17 | 65,681 | 4,674,517 | 0 | |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 106.51 | 8,853 | 942,942 | 36,543 | 45.4 K to 36.5 K (-19.50 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 106.51 | 8,853 | 942,942 | 36,543 | 45.4 K to 36.5 K (-19.50 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 105.45 | 69,003 | 7,276,504 | 45,396 | 114.4 K to 45.4 K (-60.32 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 105.45 | 69,003 | 7,276,504 | 45,396 | 114.4 K to 45.4 K (-60.32 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 106.51 | 7,423 | 790,646 | 114,399 | 121.8 K to 114.4 K (-6.09 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 106.51 | 7,423 | 790,646 | 114,399 | 121.8 K to 114.4 K (-6.09 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 105.46 | 58,258 | 6,143,772 | 121,822 | 180.1 K to 121.8 K (-32.35 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 105.46 | 58,258 | 6,143,772 | 121,822 | 180.1 K to 121.8 K (-32.35 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 66.51 | 77,865 | 5,178,801 | 180,080 | 102.2 K to 180.1 K (+76.18 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 66.51 | 77,865 | 5,178,801 | 180,080 | 102.2 K to 180.1 K (+76.18 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 71.17 | 65,681 | 4,674,517 | 102,215 | 36.5 K to 102.2 K (+179.78 %) |
Jan 03 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 71.17 | 65,681 | 4,674,517 | 102,215 | 36.5 K to 102.2 K (+179.78 %) |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 56.12 | 32,693 | 1,834,731 | 0 | |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 52.17 | 11,863 | 618,833 | 35,591 | |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 107.83 | 500 | 53,915 | 39,458 | 40 K to 39.5 K (-1.25 %) |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 107.53 | 32,193 | 3,461,552 | 39,958 | 72.2 K to 40 K (-44.62 %) |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 107.15 | 11,863 | 1,271,097 | 72,151 | 84 K to 72.2 K (-14.12 %) |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 56.12 | 32,693 | 1,834,731 | 84,014 | 51.3 K to 84 K (+63.70 %) |
Dec 04 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 52.17 | 11,863 | 618,833 | 51,321 | 39.5 K to 51.3 K (+30.06 %) |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 55.76 | 8,000 | 446,080 | 0 | |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 55.76 | 8,000 | 446,080 | 0 | |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 107.17 | 8,000 | 857,352 | 14,951 | 23 K to 15 K (-34.86 %) |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 107.17 | 8,000 | 857,352 | 14,951 | 23 K to 15 K (-34.86 %) |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 55.76 | 8,000 | 446,080 | 22,951 | 15 K to 23 K (+53.51 %) |
Nov 27 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 55.76 | 8,000 | 446,080 | 22,951 | 15 K to 23 K (+53.51 %) |
Oct 02 2019 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 288 | 0 | 8,654 | |
Oct 02 2019 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 288 | 0 | 8,654 | |
Oct 02 2019 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Option Exercise | A | 0.00 | 264 | 0 | 1,026 | |
Oct 02 2019 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Option Exercise | A | 0.00 | 264 | 0 | 1,026 | |
Sep 19 2019 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | M | 55.65 | 5,000 | 278,250 | 0 | |
Sep 19 2019 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Sell | S | 106.00 | 5,000 | 530,000 | 23,732 | 28.7 K to 23.7 K (-17.40 %) |
Sep 19 2019 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Buy | M | 55.65 | 5,000 | 278,250 | 28,671 | 23.7 K to 28.7 K (+21.12 %) |
Jul 02 2019 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Option Exercise | A | 0.00 | 275 | 0 | 755 | |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Option Exercise | M | 52.17 | 244,565 | 12,757,733 | 0 | |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Sell | S | 100.00 | 244,565 | 24,456,500 | 213,049 | 457.6 K to 213 K (-53.44 %) |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Buy | M | 52.17 | 244,565 | 12,757,733 | 457,614 | 213 K to 457.6 K (+114.79 %) |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | M | 52.17 | 73,005 | 3,808,306 | 0 | |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 100.00 | 73,005 | 7,300,500 | 66,017 | 139 K to 66 K (-52.51 %) |
Jun 17 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Buy | M | 52.17 | 73,005 | 3,808,306 | 139,022 | 66 K to 139 K (+110.59 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 1,722 | 0 | 18,057 | 16.3 K to 18.1 K (+10.54 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,722 | 0 | 14,951 | 13.2 K to 15 K (+13.02 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,722 | 0 | 38,041 | 36.3 K to 38 K (+4.74 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 1,722 | 0 | 12,125 | 10.4 K to 12.1 K (+16.55 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Grant | A | 0.00 | 1,722 | 0 | 2,212 | 490 to 2.2 K (+351.43 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 1,722 | 0 | 18,057 | 16.3 K to 18.1 K (+10.54 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,722 | 0 | 14,951 | 13.2 K to 15 K (+13.02 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,722 | 0 | 38,041 | 36.3 K to 38 K (+4.74 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 1,722 | 0 | 12,125 | 10.4 K to 12.1 K (+16.55 %) |
May 16 2019 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Grant | A | 0.00 | 1,722 | 0 | 2,212 | 490 to 2.2 K (+351.43 %) |
May 15 2019 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | A | 97.28 | 608 | 59,146 | 608 | |
May 15 2019 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 0.00 | 52 | 0 | 23,671 | 23.6 K to 23.7 K (+0.22 %) |
Apr 26 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | M | 60.68 | 47,574 | 2,886,552 | 0 | |
Apr 26 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 95.00 | 47,574 | 4,519,530 | 36,534 | 84.1 K to 36.5 K (-56.56 %) |
Apr 26 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Buy | M | 60.68 | 47,574 | 2,886,552 | 84,108 | 36.5 K to 84.1 K (+130.22 %) |
Apr 10 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 90.70 | 2,100 | 190,476 | 36,534 | 38.6 K to 36.5 K (-5.44 %) |
Apr 10 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 90.15 | 5,900 | 531,856 | 38,634 | 44.5 K to 38.6 K (-13.25 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 71.17 | 60,492 | 4,305,216 | 0 | |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 90.59 | 5,890 | 533,587 | 67,526 | 73.4 K to 67.5 K (-8.02 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 90.59 | 60,492 | 5,480,152 | 73,416 | 133.9 K to 73.4 K (-45.17 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 71.17 | 60,492 | 4,305,216 | 133,908 | 73.4 K to 133.9 K (+82.40 %) |
Apr 03 2019 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 340 | 0 | 7,972 | |
Mar 25 2019 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Gift | G | 104.78 | 491 | 51,445 | 37,760 | 38.3 K to 37.8 K (-1.28 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Payment of Exercise | F | 86.86 | 22,698 | 1,971,548 | 213,049 | 235.7 K to 213 K (-9.63 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Grant | A | 86.86 | 38,341 | 3,330,299 | 235,747 | 197.4 K to 235.7 K (+19.42 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 86.86 | 420 | 36,481 | 6,261 | 6.7 K to 6.3 K (-6.29 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 86.86 | 1,355 | 117,695 | 6,648 | 5.3 K to 6.6 K (+25.60 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 86.86 | 5,288 | 459,316 | 66,017 | 71.3 K to 66 K (-7.42 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 86.86 | 10,736 | 932,529 | 71,305 | 60.6 K to 71.3 K (+17.73 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 86.86 | 3,777 | 328,070 | 73,416 | 77.2 K to 73.4 K (-4.89 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 86.86 | 7,669 | 666,129 | 77,193 | 69.5 K to 77.2 K (+11.03 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 86.86 | 5,839 | 507,176 | 44,534 | 50.4 K to 44.5 K (-11.59 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 86.86 | 10,225 | 888,144 | 50,321 | 40.1 K to 50.3 K (+25.50 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 86.81 | 3,892 | 337,865 | 38,311 | 42.2 K to 38.3 K (-9.22 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 86.86 | 3,777 | 328,070 | 42,151 | 45.9 K to 42.2 K (-8.22 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 86.86 | 7,669 | 666,129 | 45,928 | 38.3 K to 45.9 K (+20.04 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Payment of Exercise | F | 87.84 | 6,676 | 586,420 | 197,406 | 204.1 K to 197.4 K (-3.27 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 86.51 | 1,048 | 90,662 | 39,453 | 40.5 K to 39.5 K (-2.59 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 87.06 | 364 | 31,690 | 40,501 | 40.9 K to 40.5 K (-0.89 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 87.84 | 907 | 79,671 | 40,865 | 41.8 K to 40.9 K (-2.17 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 87.84 | 142 | 12,473 | 5,293 | 5.4 K to 5.3 K (-2.61 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 87.84 | 1,556 | 136,679 | 60,569 | 62.1 K to 60.6 K (-2.50 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 87.84 | 1,066 | 93,637 | 69,524 | 70.6 K to 69.5 K (-1.51 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 87.84 | 1,432 | 125,787 | 40,096 | 41.5 K to 40.1 K (-3.45 %) |